Measles virus used to kill cancer cells

Oct 31, 2006

U.S. researchers are starting the second of several pending molecular medicine studies in patients using measles to kill cancer cells.

Mayo Clinic Cancer Center scientists opened the new clinical study using a vaccine strain of the measles virus to attack recurrent glioblastoma multiforme -- a largely untreatable brain tumor.

"We are looking at better ways to treat some of the most lethal cancers," said Dr. Eva Galanis, oncologist and lead researcher on the glioblastoma multiforme project in the measles virus investigation. "We have shown in the laboratory and in several animal models that measles virus strains can significantly shrink glioma tumors and prolong animal survival."

The Mayo Clinic says its pursuit of oncolytic measles vaccine strains for cancer treatment is unique, growing from the most basic laboratory science to a sophisticated therapy being tested in several tumor types, including glioblastoma multiforme, recurrent ovarian cancer and multiple myeloma.

The glioblastoma multiforme study, which started Tuesday, is designed to test the safety of the virus for the treatment of gliomas and enable biological monitoring of anti-tumor activity.

Copyright 2006 by United Press International

Explore further: Researchers find chemotherapy after bladder cancer surgery improved survival

add to favorites email to friend print save as pdf

Related Stories

Scientists bring oxygen back to dead fjord

9 minutes ago

More and more of the world's waters are seriously lacking oxygen. Could we use pumps to bring oxygen and thus higher life back into these waters? A Danish/Swedish research team says yes. They installed pumps ...

Losing 1 electron switches magnetism on in dichromium

56 minutes ago

The scientists used the unique Nanocluster Trap experimental station at the BESSY II synchrotron radiation source at Helmholtz-Zentrum Berlin and published their results in the Journal Angewandte Chemie.

Korean tech start-ups offer life beyond Samsung

9 hours ago

As an engineering major at Seoul's Yonsei University, Yoon Ja-Young was perfectly poised to follow the secure, lucrative and socially prized career path long-favoured by South Korea's elite graduates.

Recommended for you

Deodorant use ok for radiotherapy patients

22 hours ago

Women undergoing radiotherapy for breast cancer can use deodorant without fear of increased underarm skin reaction, pain, itching or burning, research suggests.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.